Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Armuzzi

Showing results (241-250 of 320) with videos related to

Pageof 32
Sort By:
Microorganisms|October 28, 2023
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian StudyLoris Riccardo Lopetuso, Lucrezia Laterza, Valentina Petito, et al.
Journal of Crohn'S & Colitis|May 20, 2026
Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensusPauline Wils, Vipul Jairath, Bruce E Sands, et al.
United European Gastroenterology Journal|May 23, 2020
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centreFranco Scaldaferri, Daniela Pugliese, Giuseppe Privitera, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 18, 2019
Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: An IG-IBD studyDaniela Pugliese, Marco Daperno, Gionata Fiorino, et al.
Journal of Clinical Medicine|April 13, 2023
Comparison of Short- and Long-Term Effectiveness between Anti-TNF and Ustekinumab after Vedolizumab Failure as First-Line Therapy in Crohn's Disease: A Multi-Center Retrospective Cohort StudyAhmad Albshesh, Lian Bannon, Tali Sharar Fischler, et al.
Journal of Crohn'S & Colitis|June 4, 2018
Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre StudyLuisa Guidi, Daniela Pugliese, Tommaso Panici Tonucci, et al.
United European Gastroenterology Journal|March 21, 2023
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD studyGabriele Dragoni, Fabiana Castiglione, Cristina Bezzio, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 11, 2025
Upadacitinib is Associated With Better Clinical and Biochemical Outcomes Than Tofacitinib in Refractory, Moderate-to-severe Ulcerative ColitisBernadett Farkas, Tamás Resál, Peter L Lakatos, et al.
Nutrients|September 27, 2019
Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary CenterMarco Pizzoferrato, Roberto de Sire, Fabio Ingravalle, et al.
World Journal of Clinical Cases|November 7, 2022
Clinical and epidemiological features of ulcerative colitis patients in Sardinia, Italy: Results from a multicenter studySalvatore Magrì, Mauro Demurtas, Maria Francesca Onidi, et al.
Pageof 32

Showing results (241-250 of 320) with videos related to

Sort By:
Pageof 32
Microorganisms|October 28, 2023
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian StudyLoris Riccardo Lopetuso, Lucrezia Laterza, Valentina Petito, et al.
Journal of Crohn'S & Colitis|May 20, 2026
Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensusPauline Wils, Vipul Jairath, Bruce E Sands, et al.
United European Gastroenterology Journal|May 23, 2020
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centreFranco Scaldaferri, Daniela Pugliese, Giuseppe Privitera, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 18, 2019
Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: An IG-IBD studyDaniela Pugliese, Marco Daperno, Gionata Fiorino, et al.
Journal of Clinical Medicine|April 13, 2023
Comparison of Short- and Long-Term Effectiveness between Anti-TNF and Ustekinumab after Vedolizumab Failure as First-Line Therapy in Crohn's Disease: A Multi-Center Retrospective Cohort StudyAhmad Albshesh, Lian Bannon, Tali Sharar Fischler, et al.
Journal of Crohn'S & Colitis|June 4, 2018
Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre StudyLuisa Guidi, Daniela Pugliese, Tommaso Panici Tonucci, et al.
United European Gastroenterology Journal|March 21, 2023
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD studyGabriele Dragoni, Fabiana Castiglione, Cristina Bezzio, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 11, 2025
Upadacitinib is Associated With Better Clinical and Biochemical Outcomes Than Tofacitinib in Refractory, Moderate-to-severe Ulcerative ColitisBernadett Farkas, Tamás Resál, Peter L Lakatos, et al.
Nutrients|September 27, 2019
Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary CenterMarco Pizzoferrato, Roberto de Sire, Fabio Ingravalle, et al.
World Journal of Clinical Cases|November 7, 2022
Clinical and epidemiological features of ulcerative colitis patients in Sardinia, Italy: Results from a multicenter studySalvatore Magrì, Mauro Demurtas, Maria Francesca Onidi, et al.
Pageof 32